Minoryx Therapeutics

Minoryx Therapeutics

Minoryx Therapeutics

Minoryx is a clinical stage biotech company leading the development of new therapies for XALD and other Inborn Errors of Metabolism.
Raised
$24.8M
Follow us
Alexa global traffic share
26 Sep 2018
€21,300,000
Venture capital (Series B)

Minoryx Therapeutics Raises €21.3M in Series B Funding

FinSMEs
+1